AI English summary of an SEC filing — figures as filed

Pfizer said its Board of Directors elected Cyrus Taraporevala as a member on June 27, 2024, effective immediately.

8-KDeparture or Appointment of Directors or Certain OfficersFiled Jul 1, 2024Period of report Jun 27, 2024Summary published (UTC) Oct 26, 2026

Key points

AI summary

Pfizer said its Board of Directors elected Cyrus Taraporevala as a member on June 27, 2024, effective immediately.
The company said Cyrus Taraporevala was also appointed to and will join the Audit Committee and Compensation Committee of the Board.
Pfizer said Taraporevala (age 57) served as President and Chief Executive Officer of State Street Global Advisors from 2017 until his retirement in 2022, and that he sits on the boards of Shell plc and Bridgepoint Group plc.
Pfizer said Taraporevala has been provided an indemnification agreement and will receive compensation under the company's standard arrangements for non-employee directors. Chairman and Chief Executive Officer Albert Bourla said he brings extensive experience in investment management and financial markets.

Summary

AI-written

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Board Elects Taraporevala on June 27, 2024

Pfizer said its Board of Directors elected Cyrus Taraporevala as a member on June 27, 2024, effective immediately.

Source · Based on the filing body and exhibits

Joins Audit and Compensation Committees

The company said Cyrus Taraporevala was also appointed to and will join the Audit Committee and Compensation Committee of the Board.

Source · Based on the filing body and exhibits

Director's Professional Background

Pfizer said Taraporevala (age 57) served as President and Chief Executive Officer of State Street Global Advisors from 2017 until his retirement in 2022, and that he sits on the boards of Shell plc and Bridgepoint Group plc.

Source · Based on the filing body and exhibits

Compensation Terms and Company Comments

Pfizer said Taraporevala has been provided an indemnification agreement and will receive compensation under the company's standard arrangements for non-employee directors. Chairman and Chief Executive Officer Albert Bourla said he brings extensive experience in investment management and financial markets.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

View the original filing on SEC EDGAR ↗

Unauthorized scraping, data storage and database creation prohibited

Without prior written consent, you must not crawl or scrape data compiled and organized by Chickstock or its analysis and summaries, or collect them repeatedly or in bulk for storage, ingestion or database creation. Repurposing, redistribution, sale and use to build other services are also prohibited.

Unauthorized use may result in access restrictions, demands to stop infringement and delete copies, and claims for damages. Violations of applicable law may also give rise to criminal liability.

Uses permitted by law, the Terms of Service or a separate agreement remain subject to their respective scope. Rights in individual source materials, including original filings, remain with their respective rights holders.